Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synlogic and Caldera sign merger agreement
Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.
Ulcerative Colitis
-
30 Jul 2026
-
03 Aug 2023
InDex receives new formulation patent in Europe for ulcerative colitis drug
InDex Pharmaceuticals has received a new formulation patent in Europe for the drug candidate cobitolimod which is under assessment for ulcerative colitis.